The fact that the effect of dapagliflozin on UACR alone did not reach statistical significance is likely due to the relative low number of patients included.
← all excerpts
Additive effects of dapagliflozin and finerenone on albuminuria in non-diabetic CKD: an open-label randomized clinical trial.
1
—
—